Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Nootropics Stories

2012-05-29 02:26:38

CHADDS FORD, Pa., May 29, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) announced today that it has reached an agreement with Watson Pharmaceuticals (Watson) resolving two patent infringement lawsuits related to LIDODERM (lidocaine patch 5%). A trial was held on the first of these cases in February 2012, and this resolution was reached prior to the Judge issuing a decision in the case. "We are pleased to have reached an agreement that protects Endo's intellectual property interests and...

2012-05-08 13:47:06

Misuse of prescription drugs seen as 'more necessary' for success, study finds In the eyes of young college men, it's more unethical to use steroids to get an edge in sports than it is to use prescription stimulants to enhance one's grades, according to new research published by the American Psychological Association. And students who had themselves used stimulants without a prescription were more inclined to see such drug use as acceptable, according to the findings, which were...

2012-05-07 06:27:08

WEST ORANGE, N.J., May 7, 2012 /PRNewswire/ -- A new non-prescription Reproductive Support Dietary Supplement, Pregnitude(TM), which contains myo-inositol (2 g), plus folic acid (200 mcg), is now available for women who are having difficulty conceiving, Everett Laboratories announced today. In clinical studies, Pregnitude has been shown to help support ovulation function and menstrual cycle regularity as well as support the quality of a woman's eggs. "Everett Labs is proud to make this new,...

2012-05-07 02:31:48

MASON, Ohio, May 7, 2012 /PRNewswire/ -- AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications. GeneSightRx ADHD analyzes variations in three genes that influence how a patient...

2012-04-30 02:25:53

PITTSBURGH, April 30, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has entered into a settlement agreement with Teva that will resolve pending patent litigation related to Nuvigil® (Armodafinil Tablets, 50 mg, 150 mg, and 250 mg). The settlement allows Mylan to begin selling generic versions of 50 mg, 150 mg, and 250 mg Nuvigil under license beginning in June 2016, or earlier under certain circumstances. Pursuant to the agreement, pending litigation will be...

2012-04-12 10:22:51

HUNTSVILLE, Ala., April 12, 2012 /PRNewswire-FirstCall/ -- Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Levetiracetam Oral Solution, 100mg/mL. Qualitest plans to begin distribution in mid-2012. The total sales for Levetiracetam Oral Solution, 100mg/mL, in the U.S. for the 12 months ending Dec. 31, 2011, were approximately $62.2 million, according to IMS Health. About Qualitest Founded in 1983, Qualitest provides affordable, high-quality...

2012-04-06 02:20:39

WOODCLIFF LAKE, N.J., April 6, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it began shipping all strengths of modafinil tablets, a generic version of Teva's Provigil® brand. Par's initial shipments will comprise generically-labeled presentations of the Provigil® product. Par acquired the U.S. marketing rights to modafinil from Teva in connection with Teva's acquisition of Cephalon in 2011. According to IMS Health data, annual...

2012-04-05 06:25:13

PITTSBURGH, April 5, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has filed suit against the U.S. Food and Drug Administration (FDA) in the U.S. District Court for the District of Columbia seeking to overturn a decision by FDA, which awarded Teva sole 180-day exclusivity for the generic version of its affiliate Cephalon's Provigil®. The Complaint alleges that Teva did not maintain valid paragraph IV (PIV) certifications...

2012-03-18 23:00:14

Adderall weight loss team is ready to answer questions at Health hound Ltd. News of the new team has spread to other sites. Houston, TX. (PRWEB) March 18, 2012 Weight loss support has reached a whole new level this week as the Adderall weight loss team begin their work at Health hound Ltd. The new team will be in charge of answering queries and questions that people have about this weight loss product. Carl Renson, one of the Directors at Health hound Ltd. said that “this new team...

2012-03-07 07:39:00

CARDIFF, Calif., March 7, 2012 /PRNewswire/ -- NeuroPerspective, the independent, monthly review of the neurotherapeutics area, has released its March issue, which reviews the field of therapeutics for Attention Deficit Disorder (ADHD). "There are those that claim that ADHD is a fabrication, a ruse by pharmaceutical companies to ensnare children in a psychotropic web in the name of corporate profits. Even well-regarded media outlets like the New York Times have recently run guest commentary...